- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00379548
Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study
A Pilot Study of the Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diet to Typical American Diets
We hypothesize that Asian Americans compared to Caucasians, will be at higher risk of developing a pro-inflammatory state that may contribute to the development of heart disease and diabetes when they change from a traditional Asian diet to a typical Western diet. These inflammatory responses will be reflected by the activation of monocytes as measured by protein kinase C (PKC), a known activator of monocytes.
We also hypothesize that the changes of these inflammatory responses in the gingival crevicular fluid (GCF) will reflect similar changes of these markers in the plasma and monocytes.
Specific aims:
- To compare the inflammatory responses (primarily PKC activation in monocytes), between Far-East Asian Americans and Caucasian Americans, when they change from a traditional Asian diet to a typical American diet.
- To correlate the biochemical changes of inflammatory responses in the plasma and monocytes with those in the gingival crevicular fluid (GCF).
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Joslin Diabetes Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Caucasian or Far-East Asian decent
- Ages between 25 - 55 years old
- Has family history of diabetes defined as having a first degree relative diagnosed with diabetes mellitus, and/or medical history of gestational diabetes (GDM), impaired fasting glucose(IFG) and impaired glucose tolerance (IGT)
- BMI of 18.5 - 25.0 kg/m2
- Agree to maintain constant physical activity levels for the duration of the study
- Agree to utilize contraception for the duration of the study (for female subjects)
- Have a minimum of 12 natural teeth
- Scoring of 2 or more on dental screening questionnaire (See appendix)
- Ability to communicate in English
Exclusion Criteria:
- Acute weight loss/weight gain over the past 6 months (defined as +4 lbs or more/month)
- History of diabetes
- Current Smokers (including those who quit < 1 year)
- Heavy alcohol drinkers, defined as drinking more than 7 drinks/week. Those who drink alcohol will need to be reported and documented. They will be asked to maintain the levels of alcohol consumption throughout the study.
- Medical history of vascular diseases (CAD, MI, stroke, CABG, angioplasty), diabetes, liver disease, kidney disease, cancer, AIDS, bleeding disorders
- History of food allergies or to any food products in the diet menu.
- Enrolled in another investigational study within 1 month prior to screening for this study
- Vegetarian, those with significant food aversions, and anyone who cannot comply with the diet
- Pregnancy or breasting feeding
- Other autoimmune or inflammatory conditions or diseases that may compromise the patient's safety or compliance during the study on an individual basis
- Chronic use of antibiotics or anti-inflammatory medications (>1 month) within the past year
- On medications such as statins, angiotensin converting enzyme inhibitor, warfarin, aspirin or other anti-inflammatory medications. Daily multivitamins are permitted, excluding pharmacological doses of anti- oxidants will not be allowed.
- Individuals with dental needs requiring extensive dental restorations such as cavities, root canals, crowns, etc.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: 1
Control group- subjects are on the Asian diet for the entire duration of the study
|
|
Experimental: 2
Asian and Caucasian subjects switch from an Asian Diet to a Western Diet midway through the study.
|
Intervention groups include: Asian intervention and Caucasian intervention- both these groups switch from an Asian diet to a Western diet halfway through the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in inflammatory markers including PKC and IL6 and Gingival Crevicular Fluid
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
Lipid profiles
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
Blood glucose levels
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
Body Fat percentage assessed by Dual X-ray Absorption
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
Insulin resistance assessed by HOMA
Time Frame: before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
before Asian Diet, after 8 weeks of Asian Diet, after 8 weeks of Western Diet
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: George L King, MD, Joslin Diabetes Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 04-47
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammation
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedSystemic Inflammation | Airway InflammationDenmark
-
Sykehuset TelemarkRikshospitalet University Hospital; Helse Sor-OstCompletedAirway Inflammation | Peripheral Blood Inflammation Markers | Cement Dust ExposureNorway
-
Assistance Publique - Hôpitaux de ParisCompletedDigestive InflammationFrance
-
Pamukkale UniversityCompletedPeriodontal InflammationTurkey
-
Universidade Federal do ParaCompleted
-
KLE Society's Institute of Dental SciencesCompletedRegenerative InflammationIndia
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Singapore National Eye CentreCompletedIntraocular Inflammation in ChildrenSingapore
Clinical Trials on 2 groups of population responding to 2 types of diets
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedSurgical Procedure, UnspecifiedUnited States
-
G.ST Antivirals GmbHRecruitingAcute NasopharyngitisNetherlands
-
Seoul National University HospitalCompletedProstatic Neoplasm | Urinary Bladder NeoplasmKorea, Republic of
-
Xiamen Ophthalmology Center Affiliated to Xiamen...Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...Active, not recruitingCervical Cancer | Condylomata AcuminataChina
-
General Hospital of Ningxia Medical UniversityCompleted
-
Postgraduate Institute of Dental Sciences RohtakUnknownPulpitis - IrreversibleIndia
-
Vanderbilt UniversityCompletedSurgical Site InfectionUnited States
-
Zurex Pharma, Inc.CompletedSurgical Site InfectionUnited States
-
Beijing Friendship HospitalPeking Union Medical College Hospital; Beijing Tiantan Hospital; Beijing Hospital and other collaboratorsCompleted